Transfer through membranes passive diffusion

Chemicals have to pass through either the skin or mucous membranes lining the respiratory airways and gastrointestinal tract to enter the circulation and reach their site of action. This process is called absorption. Different mechanisms of entry into the body also greatly affect the absorption of a compound. Passive diffusion is the most important transfer mechanism. According to Pick s law, diffusion velocity v depends on the diffusion constant (D), the surface area of the membrane (A), concentration difference across the membrane (Ac), and thickness of the membrane (L)... 

A thorough discussion of the mechanisms of absorption is provided in Chapter 4. Water-soluble vitamins (B2, B12, and C) and other nutrients (e.g., monosaccharides, amino acids) are absorbed by specialized mechanisms. With the exception of a number of antimetabolites used in cancer chemotherapy, L-dopa, and certain antibiotics (e.g., aminopenicillins, aminoceph-alosporins), virtually all drugs are absorbed in humans by a passive diffusion mechanism. Passive diffusion indicates that the transfer of a compound from an aqueous phase through a membrane may be described by physicochemical laws and by the properties of the membrane. The membrane itself is passive in that it does not partake in the transfer process but acts as a simple barrier to diffusion. The driving force for diffusion across the membrane is the concentration gradient (more correctly, the activity gradient) of the compound across that membrane. This mechanism of... 

In addition to the passive diffusional processes over lipid membranes or between cells, substances can be transferred through the lipid phase of biological membranes through specialized systems, i.e., active transport and facilitated diffusion. Until recently, the active transport component has been discussed only for nutrients or endogenous substances (e.g., amino acids, sugars, bile acids, small peptides), and seemed not to play any major role in the absorption of pharmaceuticals. However, sufficient evidence has now been gathered to recognize the involvement of transporters in the disposition of pharmaceuticals in the body [50, 127]. 

An important performance characteristic of passive samplers that operate in the TWA regime is the diffusion barrier that is inserted between the sampled medium and the sorption phase. This barrier is intended to control the rate of mass transfer of analyte molecules to the sorption phase. It is also used to define the selectivity of the sampler and prevent certain classes (e.g., polar or nonpolar compounds) of analytes, molecular sizes, or species from being sequestered. The resistance to mass transfer in a passive sampler is, however, seldom caused by a single barrier (e.g., a polymeric membrane), but equals the sum of the resistances posed by the individual media (e.g., aqueous boundary layer, biofilm, and membrane) through which analyte diffuses from the bulk water phase to the sorption phase.19 The individual resistances are equal to the reciprocal value of their respective mass transfer coefficients and are additive. They are directly proportional to the thickness of the barrier... 

It is not uncommon for drug compounds to be able to perform very well in a variety of microtiter plate-based assays, but when transferred to in vivo assays, they cannot reach the therapeutic target site. The molecule must permeate through a number of cell membranes made up of phospholipid bilayers, which can increase the passage of highly charged polar molecules. Among the most common means by which a molecule can cross such a membrane are transcellular routes such as passive diffusion, carrier-mediated active transport, and metabolic enzymes, paracellular... 

Oral bioavailability, a fraction of the oral dose that reaches blood circulation, is also a multimechanism phenomenon. It depends on the drug s solubility, chemical and metabolic stability, and membrane permeability. Most compounds are absorbed through passive diffusion across the membrane, while some are transferred by a carrier or by transporter molecules residing in the membrane. 

The membrane plays a passive role in drug absorption during passive diffusion most drugs pass through membrane by this mechanism. The rate of drug transfer is determined by the physicochemical properties of the drug and the drug... 

There are, however, various types of active transport systems, involving protein carriers and known as uniports, symports, and antiports as indicated in Figure 3.7. Thus, symports and antiports involve the transport of two different molecules in either the same or a different direction. Uniports are carrier proteins, which actively or passively (see section "Facilitated Diffusion") transport one molecule through the membrane. Active transport requires a source of energy, usually ATP, which is hydrolyzed by the carrier protein, or the cotransport of ions such as Na+ or H+ down their electrochemical gradients. The transport proteins usually seem to traverse the lipid bilayer and appear to function like membrane-bound enzymes. Thus, the protein carrier has a specific binding site for the solute or solutes to be transferred. For example, with the Na+/K+ ATPase antiport, the solute (Na+) binds to the carrier on one side of... 

It is thus evident that in order to be absorbed, distributed and eliminated drug molecules have to pass through a number of biological membranes of different kinds. In the vast majority of cases the transfer of drug molecules occurs by simple diffusion which is a passive process not requiring a supply of external energy. In a limited number of cases, facilitated diffusion, active transport or even pinocytosis (engulfing of substances by the membrane) are involved. 

---